Developmental Changes in the ECG of a Hamster Model of Muscular Dystrophy and Heart Failure

Aberrant autonomic signaling is being increasingly recognized as an important symptom in neuromuscular disorders. The delta-sarcoglycan-deficient BIO TO-2 hamster is recognized as a good model for studying mechanistic pathways and sequelae in muscular dystrophy and heart failure, including autonomi...

Full description

Bibliographic Details
Main Authors: Thomas Gerard Hampton, Ajit eKale, Scott eMcCue, Hemmi eBhagavan, Case eVanDongen
Format: Article
Language:English
Published: Frontiers Media S.A. 2012-05-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fphar.2012.00080/full
id doaj-983ea311879f4a979e6b416a28ebeeb0
record_format Article
spelling doaj-983ea311879f4a979e6b416a28ebeeb02020-11-24T23:02:05ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122012-05-01310.3389/fphar.2012.0008025415Developmental Changes in the ECG of a Hamster Model of Muscular Dystrophy and Heart FailureThomas Gerard Hampton0Ajit eKale1Scott eMcCue2Hemmi eBhagavan3Case eVanDongen4The Neuroscience Discovery CoreMouse Specifics, Inc.Mouse Specifics, Inc.BioBreeders, Inc.BioBreeders, Inc.Aberrant autonomic signaling is being increasingly recognized as an important symptom in neuromuscular disorders. The delta-sarcoglycan-deficient BIO TO-2 hamster is recognized as a good model for studying mechanistic pathways and sequelae in muscular dystrophy and heart failure, including autonomic nervous system dysfunction. Recent studies using the TO-2 hamster model have provided promising preclinical results demonstrating the efficacy of gene therapy to treat skeletal muscle weakness and heart failure. Methods to accelerate preclinical testing of gene therapy and new drugs for neuromuscular diseases are urgently needed. The purpose of this investigation was to demonstrate a rapid non-invasive screen for characterizing the autonomic nervous system imbalance in dystrophic TO-2 hamsters. Electrocardiograms were recorded non-invasively in conscious ~9-month old TO-2 hamsters (n=10) and non-myopathic F1B control hamsters (n=10). Heart rate was higher in TO-2 hamsters than controls (453 ± 12 bpm vs. 311 ± 25 bpm, P<0.01). Time domain heart rate variability, an index of parasympathetic tone, was lower in TO-2 hamsters (12.2 ± 3.7 bpm vs. 38.2 ± 6.8, P<0.05), as was the coefficient of variance of the RR interval (2.8 ± 0.9 % vs. 16.2 ± 3.4 %, P<0.05) compared to control hamsters. Power spectral analysis demonstrated reduced high frequency and low frequency contributions, indicating autonomic imbalance with increased sympathetic tone and decreased parasympathetic tone in dystrophic TO-2 hamsters. Similar observations in newborn hamsters indicate autonomic nervous dysfunction may occur quite early in life in neuromuscular diseases. Our findings of autonomic abnormalities in newborn hamsters with a mutation in the delta-sarcoglycan gene suggest approaches to correct modulation of the heart rate as prevention or therapy for muscular dystrophies.http://journal.frontiersin.org/Journal/10.3389/fphar.2012.00080/fullAutonomic Nervous SystemHeart Failuredevelopmenthamstersdelta-sarcoglycan deficiencyBIO TO-2 hamsters
collection DOAJ
language English
format Article
sources DOAJ
author Thomas Gerard Hampton
Ajit eKale
Scott eMcCue
Hemmi eBhagavan
Case eVanDongen
spellingShingle Thomas Gerard Hampton
Ajit eKale
Scott eMcCue
Hemmi eBhagavan
Case eVanDongen
Developmental Changes in the ECG of a Hamster Model of Muscular Dystrophy and Heart Failure
Frontiers in Pharmacology
Autonomic Nervous System
Heart Failure
development
hamsters
delta-sarcoglycan deficiency
BIO TO-2 hamsters
author_facet Thomas Gerard Hampton
Ajit eKale
Scott eMcCue
Hemmi eBhagavan
Case eVanDongen
author_sort Thomas Gerard Hampton
title Developmental Changes in the ECG of a Hamster Model of Muscular Dystrophy and Heart Failure
title_short Developmental Changes in the ECG of a Hamster Model of Muscular Dystrophy and Heart Failure
title_full Developmental Changes in the ECG of a Hamster Model of Muscular Dystrophy and Heart Failure
title_fullStr Developmental Changes in the ECG of a Hamster Model of Muscular Dystrophy and Heart Failure
title_full_unstemmed Developmental Changes in the ECG of a Hamster Model of Muscular Dystrophy and Heart Failure
title_sort developmental changes in the ecg of a hamster model of muscular dystrophy and heart failure
publisher Frontiers Media S.A.
series Frontiers in Pharmacology
issn 1663-9812
publishDate 2012-05-01
description Aberrant autonomic signaling is being increasingly recognized as an important symptom in neuromuscular disorders. The delta-sarcoglycan-deficient BIO TO-2 hamster is recognized as a good model for studying mechanistic pathways and sequelae in muscular dystrophy and heart failure, including autonomic nervous system dysfunction. Recent studies using the TO-2 hamster model have provided promising preclinical results demonstrating the efficacy of gene therapy to treat skeletal muscle weakness and heart failure. Methods to accelerate preclinical testing of gene therapy and new drugs for neuromuscular diseases are urgently needed. The purpose of this investigation was to demonstrate a rapid non-invasive screen for characterizing the autonomic nervous system imbalance in dystrophic TO-2 hamsters. Electrocardiograms were recorded non-invasively in conscious ~9-month old TO-2 hamsters (n=10) and non-myopathic F1B control hamsters (n=10). Heart rate was higher in TO-2 hamsters than controls (453 ± 12 bpm vs. 311 ± 25 bpm, P<0.01). Time domain heart rate variability, an index of parasympathetic tone, was lower in TO-2 hamsters (12.2 ± 3.7 bpm vs. 38.2 ± 6.8, P<0.05), as was the coefficient of variance of the RR interval (2.8 ± 0.9 % vs. 16.2 ± 3.4 %, P<0.05) compared to control hamsters. Power spectral analysis demonstrated reduced high frequency and low frequency contributions, indicating autonomic imbalance with increased sympathetic tone and decreased parasympathetic tone in dystrophic TO-2 hamsters. Similar observations in newborn hamsters indicate autonomic nervous dysfunction may occur quite early in life in neuromuscular diseases. Our findings of autonomic abnormalities in newborn hamsters with a mutation in the delta-sarcoglycan gene suggest approaches to correct modulation of the heart rate as prevention or therapy for muscular dystrophies.
topic Autonomic Nervous System
Heart Failure
development
hamsters
delta-sarcoglycan deficiency
BIO TO-2 hamsters
url http://journal.frontiersin.org/Journal/10.3389/fphar.2012.00080/full
work_keys_str_mv AT thomasgerardhampton developmentalchangesintheecgofahamstermodelofmusculardystrophyandheartfailure
AT ajitekale developmentalchangesintheecgofahamstermodelofmusculardystrophyandheartfailure
AT scottemccue developmentalchangesintheecgofahamstermodelofmusculardystrophyandheartfailure
AT hemmiebhagavan developmentalchangesintheecgofahamstermodelofmusculardystrophyandheartfailure
AT caseevandongen developmentalchangesintheecgofahamstermodelofmusculardystrophyandheartfailure
_version_ 1725637489277796352